Vigilance is the EU MDR system for reporting and investigating serious incidents and Field Safety Corrective Actions (FSCA) involving medical devices.
Complete Guide to Vigilance
Vigilance is the post-market surveillance system mandated by the EU Medical Device Regulation (MDR 2017/745) for monitoring, reporting, and investigating serious incidents and safety issues involving medical devices. It ensures prompt identification and mitigation of device-related risks to protect patient and user safety.
What constitutes a Serious Incident?
A serious incident is any malfunction or deterioration of a device, or any inadequacy in labeling or instructions that:
- Led to death or serious deterioration in health
- Might lead to death or serious deterioration in health
- Led to or might lead to temporary or permanent injury
Vigilance Reporting Requirements:
Manufacturer Obligations:
- Report serious incidents to competent authorities
- Report Field Safety Corrective Actions (FSCA)
- Investigate incidents thoroughly
- Take corrective actions when needed
- Maintain vigilance database and records
Reporting Timelines:
- Death or imminent risk to life - Immediately (within 2 calendar days)
- Serious deterioration in health - Within 10 calendar days
- Other serious incidents - Within 15 calendar days
- Trend reporting - As soon as detected
Field Safety Corrective Actions (FSCA):
FSCAs are actions taken to reduce risk of death or serious deterioration in health:
- Recall - Return of device to manufacturer
- Modification - Changes to device or software
- Advice - Information to users about device use
- Reports must be submitted before or immediately after implementation
Field Safety Notice (FSN):
Communication to users and customers about:
- Nature of the safety issue
- Devices affected (models, serial numbers)
- Actions users must take
- Timeline for completion
- Contact information for questions
EUDAMED Integration:
All vigilance reports must be submitted through EUDAMED (European Database on Medical Devices):
- Electronic vigilance reporting module
- Centralized database for all EU countries
- Improved transparency and data sharing
- Public access to certain vigilance data
Competent Authority Actions:
National competent authorities may:
- Request additional information
- Conduct inspections
- Require additional corrective actions
- Issue safety communications
- Suspend or withdraw certifications
Key Differences from Other Regions:
- USA (FDA) - Medical Device Reporting (MDR)
- Canada - Mandatory Problem Reporting
- Australia (TGA) - Incident reporting scheme
- Japan (PMDA) - Adverse event reporting
Vigilance Documentation Requirements:
- Incident investigation reports
- Root cause analysis
- Risk assessment updates
- CAPA (Corrective and Preventive Actions)
- Trend analysis reports
- Communication records with authorities
Penalties for Non-Compliance:
- Fines up to โฌ1 million or 7% of annual turnover
- Device recalls or market withdrawal
- Certificate suspension or revocation
- Criminal liability in severe cases
Effective vigilance ensures continuous device safety monitoring and rapid response to emerging risks throughout the product lifecycle.
Related Terms
More Clinical & Post-Market
View allAny undesirable experience associated with the use of a medical device, including patient harm, injury, malfunction, or near-miss incidents that must be reported to regulatory authorities.
A systematic evaluation comparing the clinical benefits of a medical device against its risks to determine acceptability for intended use.
A comprehensive document required under EU MDR that evaluates and documents clinical data to demonstrate a medical device's safety and performance.
A systematic study conducted on human subjects to assess the safety and performance of a medical device, required under EU regulations for certain devices before CE marking.
Need Help with EU Registration?
Pure Global provides regulatory consulting and AI-powered tools to help medical device companies navigate EU market access.

